{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:37:53Z","timestamp":1793763473593,"version":"4.6.1"},"reference-count":49,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Long-term survivors of childhood Hodgkin lymphoma (HL) experience a high burden of chronic health morbidities. Correlates of neurocognitive and psychosocial morbidity have not been well established. A total of 1760 survivors of HL (mean \u00b1 SD age, 37.5 \u00b1 6.0 years; time since diagnosis, 23.6 \u00b1 4.7 years; 52.1% female) and 3180 siblings (mean age, 33.2 \u00b1 8.5 years; 54.5% female) completed cross-sectional surveys assessing neurocognitive function, emotional distress, quality of life, social attainment, smoking, and physical activity. Treatment exposures were abstracted from medical records. Chronic health conditions were graded according to the National Cancer Institute\u2019s Common Terminology Criteria for Adverse Events version 4.3 (1 = mild, 2 = moderate, 3 = severe\/disabling, and 4\u00a0= life-threatening). Multivariable analyses, adjusted for age, sex, and race, estimated relative risk (RR) of impairment in survivors vs siblings and, among survivors, risk of impairment associated with demographic, clinical, treatment, and grade 2 or higher chronic health conditions. Compared with siblings, survivors had significantly higher risk (all, P &amp;lt; .05) of neurocognitive impairment (eg, memory, 8.1% vs 5.7%), anxiety (7.0% vs 5.4%), depression (9.1% vs 7%), unemployment (9.6% vs 4.4%), and impaired physical\/mental quality of life (eg, physical function, 11.2% vs 3.0%). Smoking was associated with a higher risk of impairment in task efficiency (RR, 1.56; 95% confidence interval [CI], 1.02-2.39), emotional regulation (RR, 1.84; 95% CI, 1.35-2.49), anxiety (RR, 2.43; 95% CI, 1.51-3.93), and depression (RR, 2.73; 95% CI, 1.85-4.04). Meeting the exercise guidelines of the Centers for Disease Control and Prevention was associated with a lower risk of impairment in task efficiency (RR, 0.70; 95% CI, 0.52-0.95), organization (RR, 0.60; 95% CI, 0.45-0.80), depression (RR, 0.66; 95% CI, 0.48-0.92), and multiple quality of life domains. Cardiovascular and neurologic conditions were associated with impairment in nearly all domains. Survivors of HL are at elevated risk for neurocognitive and psychosocial impairment, and risk is associated with modifiable factors that provide targets for interventions to improve long-term functional outcomes.<\/jats:p>","DOI":"10.1182\/blood.2021013167","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T19:58:55Z","timestamp":1638561535000},"page":"3073-3086","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":22,"title":["Modifiable risk factors for neurocognitive and psychosocial problems after Hodgkin lymphoma"],"prefix":"10.1182","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7042-5851","authenticated-orcid":false,"given":"AnnaLynn M.","family":"Williams","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Cancer Control,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8240-5957","authenticated-orcid":false,"given":"Sedigheh","family":"Mirzaei Salehabadi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2021-4036","authenticated-orcid":false,"given":"Nicholas S.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2781-9983","authenticated-orcid":false,"given":"Matthew J.","family":"Ehrhardt","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control,"},{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Howell","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yasui","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Oeffinger","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University and Duke Cancer Institute, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Gibson","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, Radiation Epidemiology Branch, National Cancer Institute, Rockville, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Chow","sequence":"additional","affiliation":[{"name":"Clinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7405-0906","authenticated-orcid":false,"given":"Wendy","family":"Leisenring","sequence":"additional","affiliation":[{"name":"Clinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deokumar","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-2407","authenticated-orcid":false,"given":"Melissa M.","family":"Hudson","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control,"},{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7460-8578","authenticated-orcid":false,"given":"Leslie L.","family":"Robison","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0476-7001","authenticated-orcid":false,"given":"Kevin R.","family":"Krull","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control,"},{"name":"Department of Psychology, St. Jude\u00a0Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2022051915251255000_B1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3322\/caac.21219","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J Clin."},{"issue":"9","key":"2022051915251255000_B2","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S1470-2045(16)30215-7","article-title":"Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin\u2019s lymphoma: an analysis from the St Jude Lifetime Cohort Study","volume":"17","author":"Bhakta","year":"2016","journal-title":"Lancet Oncol."},{"issue":"5","key":"2022051915251255000_B3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/bjh.13903","article-title":"Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood\/Adolescent\/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer","volume":"172","author":"Bhuller","year":"2016","journal-title":"Br J Haematol."},{"issue":"6","key":"2022051915251255000_B4","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2010-04-278796","article-title":"Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study","volume":"117","author":"Castellino","year":"2011","journal-title":"Blood."},{"issue":"9","key":"2022051915251255000_B5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJMoa1510795","article-title":"Reduction in late mortality among 5-year survivors of childhood cancer","volume":"374","author":"Armstrong","year":"2016","journal-title":"N Engl J Med."},{"issue":"2","key":"2022051915251255000_B6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3803\/EnM.2014.29.2.112","article-title":"Neurocognitive changes and their neural correlates in patients with type 2 diabetes mellitus","volume":"29","author":"Lee","year":"2014","journal-title":"Endocrinol Metab (Seoul)."},{"issue":"7","key":"2022051915251255000_B7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/arclin\/16.7.643","article-title":"Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease","volume":"16","author":"Crews","year":"2001","journal-title":"Arch Clin Neuropsychol."},{"issue":"6","key":"2022051915251255000_B8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000109811","article-title":"Neuroimaging and correlates of cognitive function among patients with heart failure","volume":"24","author":"Vogels","year":"2007","journal-title":"Dement Geriatr Cogn Disord."},{"issue":"14","key":"2022051915251255000_B9","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1200\/JCO.2009.22.3339","article-title":"The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research","volume":"27","author":"Robison","year":"2009","journal-title":"J\u00a0Clin Oncol."},{"issue":"14","key":"2022051915251255000_B10","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1200\/JCO.2008.21.1813","article-title":"Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study","volume":"27","author":"Leisenring","year":"2009","journal-title":"J Clin Oncol."},{"issue":"8","key":"2022051915251255000_B11","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/cncr.23809","article-title":"Reliability and validity of the Childhood Cancer Survivor Study Neurocognitive Questionnaire","volume":"113","author":"Krull","year":"2008","journal-title":"Cancer."},{"issue":"1","key":"2022051915251255000_B12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ije\/dyaa203","article-title":"Cohort profile: the St. Jude Lifetime Cohort Study (SJLIFE) for paediatric cancer survivors","volume":"50","author":"Howell","year":"2021","journal-title":"Int J Epidemiol."},{"issue":"1","key":"2022051915251255000_B13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1037\/1040-3590.18.1.22","article-title":"Factor structure of the Brief Symptom Inventory-18 in adult survivors of childhood cancer: results from the Childhood Cancer Survivor Study","volume":"18","author":"Recklitis","year":"2006","journal-title":"Psychol Assess."},{"issue":"2","key":"2022051915251255000_B14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/1055-9965.EPI-07-2541","article-title":"Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the Childhood Cancer Survivor Study","volume":"17","author":"Zeltzer","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"4","key":"2022051915251255000_B15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/jnci\/djaa102","article-title":"Long-term neurocognitive and psychosocial outcomes after acute myeloid leukemia: a Childhood Cancer Survivor Study Report","volume":"113","author":"Stefanski","year":"2021","journal-title":"J\u00a0Natl Cancer Inst."},{"key":"2022051915251255000_B16","article-title":"Behavioral Risk Factor Surveillance System State Questionnaire","author":"BRFSS"},{"issue":"9","key":"2022051915251255000_B17","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/cncr.24209","article-title":"Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"115","author":"Ness","year":"2009","journal-title":"Cancer."},{"issue":"20","key":"2022051915251255000_B18","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1200\/JCO.20.01186","article-title":"Impact of risk-adapted therapy for pediatric Hodgkin lymphoma on risk of long-term morbidity: a report from the Childhood Cancer Survivor Study","volume":"39","author":"Oeffinger","year":"2021","journal-title":"J Clin Oncol."},{"issue":"15","key":"2022051915251255000_B19","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med."},{"issue":"6","key":"2022051915251255000_B20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3200\/JOER.99.6.323-338","article-title":"Reporting structural equation modeling and confirmatory factor analysis results: a review","volume":"99","author":"Schreiber","year":"2006","journal-title":"J Educ Res."},{"issue":"3","key":"2022051915251255000_B21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ana.25981","article-title":"Childhood neurotoxicity and brain resilience to adverse events during adulthood","volume":"89","author":"Williams","year":"2021","journal-title":"Ann Neurol."},{"issue":"4","key":"2022051915251255000_B22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jnci\/djx224","article-title":"Chronic health conditions and neurocognitive function in aging survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"110","author":"Cheung","year":"2018","journal-title":"J Natl Cancer Inst."},{"issue":"29","key":"2022051915251255000_B23","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2012.42.6841","article-title":"Neurocognitive function and CNS integrity in adult survivors of childhood Hodgkin lymphoma","volume":"30","author":"Krull","year":"2012","journal-title":"J Clin Oncol."},{"issue":"18","key":"2022051915251255000_B24","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1200\/JCO.19.02677","article-title":"Consistent physical activity and future neurocognitive problems in adult survivors of childhood cancers: a report from the Childhood Cancer Survivor Study","volume":"38","author":"Barlow-Krelina","year":"2020","journal-title":"J Clin Oncol."},{"issue":"17","key":"2022051915251255000_B25","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1002\/cncr.32173","article-title":"Impact of exercise on psychological burden in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"125","author":"Tonorezos","year":"2019","journal-title":"Cancer."},{"issue":"3","key":"2022051915251255000_B26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/pbc.23385","article-title":"Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies","volume":"58","author":"Hudson","year":"2012","journal-title":"Pediatr Blood Cancer."},{"issue":"1","key":"2022051915251255000_B27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/pbc.24049","article-title":"Effects of a home-based exercise program on metabolic risk factors and fitness in long-term survivors of childhood acute lymphoblastic leukemia","volume":"59","author":"J\u00e4rvel\u00e4","year":"2012","journal-title":"Pediatr Blood Cancer."},{"issue":"1","key":"2022051915251255000_B28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/cncr.30987","article-title":"Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: the Memory & Motion Study","volume":"124","author":"Hartman","year":"2018","journal-title":"Cancer."},{"issue":"1 pt 1","key":"2022051915251255000_B29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1542\/peds.110.1.42","article-title":"Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin\u2019s disease, and non-Hodgkin\u2019s lymphoma: a report from the Childhood Cancer Survivor Study","volume":"110","author":"Zebrack","year":"2002","journal-title":"Pediatrics."},{"issue":"6","key":"2022051915251255000_B30","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00520-013-2114-y","article-title":"Quality of life in long-term survivors following treatment for Hodgkin\u2019s disease during childhood and adolescence in the German multicentre studies between 1978 and 2002","volume":"22","author":"Calaminus","year":"2014","journal-title":"Support Care Cancer."},{"issue":"5","key":"2022051915251255000_B31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1200\/JCO.2014.57.4863","article-title":"Age-dependent changes in health status in the Childhood Cancer Survivor cohort","volume":"33","author":"Hudson","year":"2015","journal-title":"J Clin Oncol."},{"issue":"12","key":"2022051915251255000_B32","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.290.12.1583","article-title":"Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"290","author":"Hudson","year":"2003","journal-title":"JAMA."},{"issue":"5","key":"2022051915251255000_B33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/adc.2003.041541","article-title":"Adverse psychological effects of corticosteroids in children and adolescents","volume":"90","author":"Stuart","year":"2005","journal-title":"Arch Dis Child."},{"issue":"23","key":"2022051915251255000_B34","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1200\/JCO.2014.57.7528","article-title":"Psychosocial and neurocognitive outcomes in adult survivors of adolescent and early young adult cancer: a report from the Childhood Cancer Survivor Study","volume":"33","author":"Prasad","year":"2015","journal-title":"J Clin Oncol."},{"issue":"3","key":"2022051915251255000_B35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000087001","article-title":"Relation between the hypothalamic-pituitary-thyroid (HPT) axis and\u00a0the hypothalamic-pituitary-adrenal (HPA) axis during repeated stress","volume":"81","author":"Helmreich","year":"2005","journal-title":"Neuroendocrinology."},{"issue":"3","key":"2022051915251255000_B36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrc2073","article-title":"Candidate mechanisms for chemotherapy-induced cognitive changes","volume":"7","author":"Ahles","year":"2007","journal-title":"Nat Rev Cancer."},{"issue":"1","key":"2022051915251255000_B37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.21974","article-title":"Adult survivors of childhood cancer and unemployment: a metaanalysis","volume":"107","author":"de Boer","year":"2006","journal-title":"Cancer."},{"issue":"19","key":"2022051915251255000_B38","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1002\/cncr.27445","article-title":"Health status of adolescent and young adult cancer survivors","volume":"118","author":"Tai","year":"2012","journal-title":"Cancer."},{"issue":"4","key":"2022051915251255000_B39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/jnci\/djp498","article-title":"Educational attainment among adult survivors of childhood cancer in Great Britain: a population-based cohort study","volume":"102","author":"Lancashire","year":"2010","journal-title":"J\u00a0Natl Cancer Inst."},{"issue":"14","key":"2022051915251255000_B40","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1200\/JCO.2008.21.1458","article-title":"Social outcomes in the Childhood Cancer Survivor Study cohort","volume":"27","author":"Gurney","year":"2009","journal-title":"J Clin Oncol."},{"issue":"11","key":"2022051915251255000_B41","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/MLR.0b013e3181eaf880","article-title":"Unemployment among adult survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"48","author":"Kirchhoff","year":"2010","journal-title":"Med Care."},{"issue":"13","key":"2022051915251255000_B42","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1002\/cncr.25867","article-title":"Occupational outcomes of adult childhood cancer survivors: a report from the Childhood Cancer Survivor Study","volume":"117","author":"Kirchhoff","year":"2011","journal-title":"Cancer."},{"key":"2022051915251255000_B43","author":"Howlader"},{"issue":"32","key":"2022051915251255000_B44","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children\u2019s Oncology Group Study AHOD0031","volume":"32","author":"Friedman","year":"2014","journal-title":"J Clin Oncol."},{"issue":"24","key":"2022051915251255000_B45","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/jama.2012.5847","article-title":"Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma","volume":"307","author":"Metzger","year":"2012","journal-title":"JAMA."},{"issue":"9","key":"2022051915251255000_B46","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S1470-2045(18)30426-1","article-title":"Brentuximab vedotin with gemcitabine for\u00a0paediatric and young adult patients with relapsed or refractory Hodgkin\u2019s lymphoma (AHOD1221): a Children\u2019s Oncology Group, multicentre single-arm, phase 1-2 trial","volume":"19","author":"Cole","year":"2018","journal-title":"Lancet Oncol."},{"issue":"20","key":"2022051915251255000_B47","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1200\/JCO.20.03286","article-title":"Excellent outcome for pediatric patients with high-risk Hodgkin lymphoma treated with brentuximab vedotin and risk-adapted residual node radiation","volume":"39","author":"Metzger","year":"2021","journal-title":"J Clin Oncol."},{"issue":"7","key":"2022051915251255000_B48","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ctrv.2012.05.002","article-title":"Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review","volume":"38","author":"Hutchinson","year":"2012","journal-title":"Cancer Treat Rev."},{"issue":"1","key":"2022051915251255000_B49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study","volume":"61","author":"Green","year":"2014","journal-title":"Pediatr Blood Cancer"}],"updated-by":[{"DOI":"10.1182\/blood.2023022137","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000}}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/20\/3073\/1897345\/bloodbld2021013167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/20\/3073\/1897345\/bloodbld2021013167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T15:26:52Z","timestamp":1652974012000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/139\/20\/3073\/482888\/Modifiable-risk-factors-for-neurocognitive-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":49,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2022,5,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021013167","relation":{"erratum":[{"id-type":"doi","id":"10.1182\/blood.2023022137","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]}}}